Commercialization of biobanks.
Biobank policy and regulations profoundly vary between different societies. One area with profound differences in culture and tradition concerns commercialization, and the possibility of using the human body as a capital resource. In the United States there is acceptance of this possibility, whereas European law is based on principles that categorically prohibit selling parts of the human body. We suggest that questions of commercialization in the area of biobanking must be considered in relation to different ethical values, notably the principle of best possible use of collected biobank materials for the benefit of vital patient interests.
Centre for Research Ethics and Bioethics (CRB), Uppsala University , Uppsala, Sweden .
Kathinka
K
Evers
Joanna
J
Forsberg
Mats
M
Hansson